MENU
BRNS
AS OF
Nov 13 closing price
Price
$0.78
Change
-$0.03 (-3.70%)
Capitalization
31.93M
126 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Barinthus Biotherapeutics (BRNS) Earnings Date & Reports

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more

A.I. Advisor
published Earnings

BRNS is expected to report earnings to rise 6.94% to -38 cents per share on March 20

Barinthus Biotherapeutics BRNS Stock Earnings Reports
Q4'25
Est.
$-0.38
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.16
Q1'25
Missed
by $0.13
Q4'24
Missed
by $0.05
The last earnings report on November 07 showed earnings per share of -36 cents, beating the estimate of -40 cents. With 270.67K shares outstanding, the current market capitalization sits at 31.93M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BRNS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BRNS showed earnings on November 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BRNS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com